Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis

NCT01324037 · View on ClinicalTrials.gov ↗

Study Summary

Deep vein thrombosis (DVT) of the arm, officially called upper extremity DVT is a rare disorder and accounts for up to 1-4% of all cases of deep vein thrombosis. In case of a thrombosis, there is a blood clot in one of the veins, which should be treated with blood thinners (anticoagulants). The aim of the present study is to see whether it is safe to use a combination of tests for the diagnosis of arm thrombosis. In all patients, we will use a clinical decision rule (clinical judgement) and a laboratory test (D-dimer testing), in most patients also an ultrasound of the arm will be done. The combination of these tests was found to be safe and effective in patients with thrombosis of the legs.

Interventions

  • OTHER diagnostic algorithm

Study Locations (18)

Other

  • Medical University Graz — Graz
  • Medical University Innsbruck — Innsbruck
  • University Hospital Leuven — Leuven
  • University Hospital Dresden — Dresden
  • Ospedali Riuniti — Bergamo
  • University Hospital Bologna — Bologna
  • Hospital D'Annunziata — Chieti
  • University Hospital of Padova — Padua
  • Servizio Sanitario Regionale Emilia - Romagna — Reggio Emilia
  • Onze Lieve Vrouwe Gasthuis — Amsterdam
  • Slotervaart Hospital — Amsterdam
  • Maxima Medisch Centrum — Eindhoven/Veldhoven
  • University Medical Center Groningen — Groningen
  • Academic Hospital Maastricht — Maastricht
  • Antonius Hospital — Nieuwegein
  • Geneva University Hospital — Geneva

District of Columbia

  • Veterans Affairs Hospital — Washington D.C.

Gelderland

  • Rijnstate Hospital — Arnhem

Trial Details

FieldValue
Enrollment Target 406 participants
Start Date 2010-03
Est. Completion 2013-04
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01324037

The ClinicalTrials.gov registry entry for NCT01324037 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Medical Center Groningen, which has 3 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Suspected Upper Extremity Deep Vein Thrombosis appearing as the primary indexed condition, and to 1 intervention — of which diagnostic algorithm is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT01324037 reports 18 study locations spanning 3 distinct geographic areas — top geographies include Other, District of Columbia, Gelderland. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT01324037 about?

NCT01324037 is a clinical study titled "Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis". Deep vein thrombosis (DVT) of the arm, officially called upper extremity DVT is a rare disorder and accounts for up to 1-4% of all cases of deep vein thrombosis. In case of a thrombosis, there is a blood clot in one of the veins, which should be treated with blood thinners (anticoagulants). The aim ...

What is the current status of trial NCT01324037?

This trial is currently completed. It is a NA study. The enrollment target is 406 participants. The study started on 2010-03. Estimated completion is 2013-04.

What conditions does trial NCT01324037 study?

This clinical trial studies the following conditions: Suspected Upper Extremity Deep Vein Thrombosis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT01324037?

The interventions under investigation include: diagnostic algorithm (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT01324037?

This trial is sponsored by University Medical Center Groningen, which has 3 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT01324037 being conducted?

This trial has 18 study locations across District of Columbia, Gelderland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial